Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Other financing activities (2021 - 2026)

Biomerica's Other financing activities history spans 6 years, with the latest figure at $25000.0 for Q1 2026.

  • Quarterly results put Other financing activities at $25000.0 for Q1 2026, down 79.17% from a year ago — trailing twelve months through Feb 2026 was -$52000.0 (down 105.18% YoY), and the annual figure for FY2025 was $44000.0, down 45.68%.
  • Other financing activities for Q1 2026 was $25000.0 at Biomerica, up from -$126000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $652000.0 in Q2 2023 to a low of -$126000.0 in Q4 2025.
  • The 5-year median for Other financing activities is $25000.0 (2026), against an average of $78684.0.
  • The sharpest move saw Other financing activities soared 152951.64% in 2023, then crashed 181.29% in 2025.
  • Year by year, Other financing activities stood at $5000.0 in 2022, then soared by 12940.0% to $652000.0 in 2023, then crashed by 76.23% to $155000.0 in 2024, then crashed by 181.29% to -$126000.0 in 2025, then skyrocketed by 119.84% to $25000.0 in 2026.
  • According to Business Quant data, Other financing activities over the past three periods came in at $25000.0, -$126000.0, and $133000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.